語系:
繁體中文
English
說明(常見問題)
回圖書館首頁
手機版館藏查詢
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Role of the class I(A) phosphoinosit...
~
Luo, Ji.
FindBook
Google Book
Amazon
博客來
Role of the class I(A) phosphoinositide 3-kinase regulatory subunit p85 in metabolism, development and cancer.
紀錄類型:
書目-語言資料,印刷品 : Monograph/item
正題名/作者:
Role of the class I(A) phosphoinositide 3-kinase regulatory subunit p85 in metabolism, development and cancer./
作者:
Luo, Ji.
面頁冊數:
130 p.
附註:
Adviser: Lewis C. Cantley.
Contained By:
Dissertation Abstracts International67-02B.
標題:
Biology, Animal Physiology. -
電子資源:
http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3205929
ISBN:
9780542547188
Role of the class I(A) phosphoinositide 3-kinase regulatory subunit p85 in metabolism, development and cancer.
Luo, Ji.
Role of the class I(A) phosphoinositide 3-kinase regulatory subunit p85 in metabolism, development and cancer.
- 130 p.
Adviser: Lewis C. Cantley.
Thesis (Ph.D.)--Harvard University, 2006.
Class IA phosphoinositide 3-kinases (PI3Ks) are heterodimeric lipid kinases consisting of a p85 regulatory subunit and a p110 catalytic subunit. The p85 regulatory subunit stabilizes the p110 catalytic subunit and mediates its receptor recruitment and activation. Upon activation by growth factor receptors, class IA PI3Ks generate the lipid second messenger PIP3 at the plasma membrane. Class IA PI3K signaling critically regulates key cellular processes such as cell metabolism, growth, proliferation and survival. Dysregulation of class IA PI3K signaling is associated with several human diseases such as type-2 diabetes and cancer. My dissertation studies focused on two aspects of class I A PI3K biology: the molecular mechanism by which monomeric p85 negatively regulates class IA PI3K activation, and the in vivo role of class IA PI3K signaling in the context of growth and metabolism.
ISBN: 9780542547188Subjects--Topical Terms:
1017835
Biology, Animal Physiology.
Role of the class I(A) phosphoinositide 3-kinase regulatory subunit p85 in metabolism, development and cancer.
LDR
:03143nam 2200313 a 45
001
970624
005
20110921
008
110921s2006 eng d
020
$a
9780542547188
035
$a
(UMI)AAI3205929
035
$a
AAI3205929
040
$a
UMI
$c
UMI
100
1
$a
Luo, Ji.
$3
1294663
245
1 0
$a
Role of the class I(A) phosphoinositide 3-kinase regulatory subunit p85 in metabolism, development and cancer.
300
$a
130 p.
500
$a
Adviser: Lewis C. Cantley.
500
$a
Source: Dissertation Abstracts International, Volume: 67-02, Section: B, page: 0648.
502
$a
Thesis (Ph.D.)--Harvard University, 2006.
520
$a
Class IA phosphoinositide 3-kinases (PI3Ks) are heterodimeric lipid kinases consisting of a p85 regulatory subunit and a p110 catalytic subunit. The p85 regulatory subunit stabilizes the p110 catalytic subunit and mediates its receptor recruitment and activation. Upon activation by growth factor receptors, class IA PI3Ks generate the lipid second messenger PIP3 at the plasma membrane. Class IA PI3K signaling critically regulates key cellular processes such as cell metabolism, growth, proliferation and survival. Dysregulation of class IA PI3K signaling is associated with several human diseases such as type-2 diabetes and cancer. My dissertation studies focused on two aspects of class I A PI3K biology: the molecular mechanism by which monomeric p85 negatively regulates class IA PI3K activation, and the in vivo role of class IA PI3K signaling in the context of growth and metabolism.
520
$a
My studies demonstrated that, in response to IGF-1 signaling, monomeric p85 forms a cytosolic sequestration complex with IRS-1, an adaptor protein that mediates the activation of PI3K downstream of the insulin and the IGF-1 receptors. This sequestration complex prevents IRS-1 from activating p85-p110 heterodimers at the membrane. In addition to cell metabolism, PI3K-mediated cell growth and proliferation is also subjected to negative regulation by monomeric p85, as p85alpha+/- PTEN+/- mice show increased incidence of intestinal polyps and enhanced cell proliferation in the intestinal epithelium compared to PTEN+/- mice. To better understand the roles of class IA PI3Ks in vivo, I generated mice with tissue-specific deletion of p85 proteins. I demonstrated that mice lacking all p85 isoforms in the heart and the muscle show severely impaired PI3K signaling in these tissues, resulting in a reduction in cell and organ size. Furthermore, the loss of muscle PI3K signaling in mice leads to muscle insulin resistance, hyperlipidemia and increased adiposity. Taken together, my dissertation studies demonstrate that class IA PI3K signaling is exquisitely controlled by its p85 regulatory subunit, and class IA PI3K is an important regulator of growth and metabolism in vivo.
590
$a
School code: 0084.
650
4
$a
Biology, Animal Physiology.
$3
1017835
650
4
$a
Biology, Cell.
$3
1017686
650
4
$a
Biology, Molecular.
$3
1017719
650
4
$a
Health Sciences, Oncology.
$3
1018566
690
$a
0307
690
$a
0379
690
$a
0433
690
$a
0992
710
2 0
$a
Harvard University.
$3
528741
773
0
$t
Dissertation Abstracts International
$g
67-02B.
790
$a
0084
790
1 0
$a
Cantley, Lewis C.,
$e
advisor
791
$a
Ph.D.
792
$a
2006
856
4 0
$u
http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3205929
筆 0 讀者評論
館藏地:
全部
電子資源
出版年:
卷號:
館藏
1 筆 • 頁數 1 •
1
條碼號
典藏地名稱
館藏流通類別
資料類型
索書號
使用類型
借閱狀態
預約狀態
備註欄
附件
W9129112
電子資源
11.線上閱覽_V
電子書
EB W9129112
一般使用(Normal)
在架
0
1 筆 • 頁數 1 •
1
多媒體
評論
新增評論
分享你的心得
Export
取書館
處理中
...
變更密碼
登入